GrayMatters Health inks $10m Series A

GrayMatters Health, a developer of digital self-neuromodulation therapeutics for mental disorders, has raised $10 million in Series A financing.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this